Development and characterization of six new human papillary thyroid carcinoma cell lines. - Wikidata - awgldk - TriplyDB

Development and characterization of six new human papillary thyroid carcinoma cell lines.

Development and characterization of six new human papillary thyroid carcinoma cell lines.

http://www.wikidata.org/entity/Q35055107

about

MDA-T120 MDA-T22 MDA-T32 MDA-T41 MDA-T68 MDA-T85

P1343

Characterization of thyroid cancer cell lines in murine orthotopic and intracardiac metastasis models.

P2860

Q54904658-1E0AD838-06CD-4B64-AEF7-2FACC7111A63 Q54904659-B8BA134E-05BC-420C-B68B-136E2FC19245 Q54904660-0F2149A2-ADCE-491E-9A67-E2FBB4415004 Q54904661-F0A127B8-058E-4E0B-8C3F-CB95AC010D9B Q54904662-703CDBA6-5A02-43DD-9E0E-ED05764C6C37 Q54904663-D9CD912F-8FF6-4854-A7B3-ADABB8195A02

P1343

Q35554680-BBEF6CAC-AA44-466E-9EE8-ABFDC8091C88

P2860

Development and characterization of six new human papillary thyroid carcinoma cell lines.

http://www.wikidata.org/entity/Q35055107

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Development and characterization of six new human papillary thyroid carcinoma cell lines.

@ast

Development and characterization of six new human papillary thyroid carcinoma cell lines.

@en

type

label

Development and characterization of six new human papillary thyroid carcinoma cell lines.

@ast

Development and characterization of six new human papillary thyroid carcinoma cell lines.

@en

prefLabel

Development and characterization of six new human papillary thyroid carcinoma cell lines.

@ast

Development and characterization of six new human papillary thyroid carcinoma cell lines.

@en

P1433

Q35055107-36062364-EACA-4FCF-81FE-B2B08944C4F9

P1476

Q35055107-D6A7DB7F-02D3-475D-8861-2B97C55651B1

P2093

Q35055107-05FB839F-1C33-4419-9229-CFDE6BD80CBE

Q35055107-0A175E85-2C46-4722-9802-B5C515F2980C

Q35055107-627BE5A0-2B2E-41DA-ACD6-8FAAA1BE0D62

Q35055107-6E8CDF65-B9B5-4A7F-95BA-FC2F0450F1F1

Q35055107-858E0C83-3393-4993-B925-23EE477F068F

Q35055107-C1973D88-BFBE-47AA-928D-C3CC4EE06A6F

Q35055107-CBE6749D-C408-4910-A06B-26D88C1110B2

P2860

Q35055107-03CB531E-59FC-4017-86B2-B92159E3E320

Q35055107-0FE4DA31-43DF-4DAE-A5D0-0C50B739092D

Q35055107-19F4BBCB-D281-4E66-87A1-F37D8A4578ED

Q35055107-255F6432-877E-4D91-9AD4-B709DAFF65C0

Q35055107-295D1EA7-2D78-4984-8B95-3A3F1A717CC9

Q35055107-40716C65-6196-4787-9626-384694780F57

Q35055107-40C24502-86AB-4EC2-B979-591EC05232C5

Q35055107-4545C114-A29E-4F82-A957-9A30908C9432

Q35055107-5CB8BFEC-19F0-4C2E-A8E0-4D22DEAE5762

Q35055107-60548D7E-6827-41B4-AE0B-52CD2974E046

P304

Q35055107-FCBD6BA2-DCB5-4ECF-A2FB-3033B3608B09

P31

Q35055107-24D7230C-5681-43C5-BB03-B47BD3FFAFD3

P356

Q35055107-94AF0E35-22C9-4B72-8C75-FDBCB23D2918

P407

Q35055107-4B48A5D5-B323-4B90-BF9B-A0B0A5F6F9A8

P433

Q35055107-D137EFD4-5240-4323-92DD-7A674DF8930C

P4510

Q35055107-06DD2FB0-D51A-4E33-861D-8527862D0402

Q35055107-098EF913-D749-4E08-B047-FD1ED18C9FBC

Q35055107-1E6DE8B7-076E-476C-A287-1C0C3B7953F7

Q35055107-230541C9-17F1-4F31-8E1A-795F7B6881F8

Q35055107-AA042203-79E2-458B-85A2-F0E700033A23

Q35055107-F8FB74FD-FDE1-40BC-9F9C-DBBD08776BF1

P478

Q35055107-3951E6D0-6F6D-4287-8CAE-6B49F6BD1BC4

P50

Q35055107-1ACA1079-64FF-4FDC-B3DA-06CE9C938519

Q35055107-3BF1D6EB-BE31-4C68-94B8-C93E1D179E33

Q35055107-A27C7C9E-2E23-465F-9A25-94A2655EF3EF

Q35055107-F19F6A97-5F89-4AD3-A477-5B4B683621F4

P577

Q35055107-9B351450-D88B-488A-8525-1369C3FDF207

P5875

Q35055107-F511F540-D9BF-44B1-A2AA-948897D5A781

P698

Q35055107-60B28672-89E0-424E-B6D9-278C1A2AB757

P921

Q35055107-6550A042-48A0-429E-A08C-FF80C1A68145

P932

Q35055107-10E8FE0B-1054-45BA-A365-25F830934132

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Development and characterization of six new human papillary thyroid carcinoma cell lines

@en

P2093

Adel K El-Naggar

http://www.w3.org/2001/XMLSchema#string

Bryan R Haugen

http://www.w3.org/2001/XMLSchema#string

Gary L Clayman

http://www.w3.org/2001/XMLSchema#string

Mihai Gagea

http://www.w3.org/2001/XMLSchema#string

Soon-Hyun Ahn

http://www.w3.org/2001/XMLSchema#string

Ying C Henderson

http://www.w3.org/2001/XMLSchema#string

Yunyun Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.

RAS oncogenes: weaving a tumorigenic web

TERT promoter mutations in familial and sporadic melanoma

Ras oncogenes: split personalities

RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers.

MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo

Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target.

High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites.

P304

E243-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2014-2624

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P4510

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Michelle D Williams

Rebecca Schweppe

P577

2014-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268875650

http://www.w3.org/2001/XMLSchema#string

P698

25427145

http://www.w3.org/2001/XMLSchema#string

P921

P932

4318904

http://www.w3.org/2001/XMLSchema#string